MENU
Aim higher

TolerizeMG

A unique tolerance inducing therapy for the treatment of the Orphan disease Myasthenia Gravis (MG)

Start date: 
01-04-2015
Project Duration: 
14months
Technological Area: 
In vitro Testing, Trials
Market Area: 
Therapeutic services